Cite
MLA Citation
Jaclyn A Smith et al.. “Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial.” Lancet, vol. 8, no. 8, 2020, pp. 775–785. http://access.bl.uk/ark:/81055/vdc_100105903037.0x000009